Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant987 active trials8 approved drugs63 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,216 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05088889 | Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer | unknown | Phase 1 | 10 | Sheba Medical CenterOTHER_GOV | 1 | Nov 28, 2023 | clinicaltrials |
| NCT05964621 | Venous Thromboembolism in Primary Pancreatic Tumour Resection(PaTR-VTE) | unknown | — | 64 | University of ThessalyOTHER | 1 | Nov 28, 2023 |
| NCT05580445 | Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 114 | Shouyao Holdings (Beijing) Co. LTDOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT04338763 | RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer | unknown | Phase 1 | 48 | Rise Biopharmaceuticals, Inc.INDUSTRY | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06134765 | Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer | unknown | Phase 2 | 89 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06135649 | Dissecting the Pattern of Nodal Spread in Post-neoadjuvant Pancreatoduodenectomy | unknown | — | 850 | Universita di VeronaOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05147168 | Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version in Taiwan | unknown | — | 300 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Nov 14, 2023 | clinicaltrials |
| NCT05523778 | A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct | unknown | N/A | 78 | Peking Union Medical College HospitalOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT05498597 | AMT-151 in Patients With Selected Advanced Solid Tumours | unknown | Phase 1 | 30 | Multitude Therapeutics Inc.INDUSTRY | 2 | Oct 19, 2023 | clinicaltrials |
| NCT06090825 | Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient | unknown | — | 450 | Peking Union Medical College HospitalOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT03129139 | A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors(Minnelide 101) | unknown | Phase 1 | 66 | Minneamrita Therapeutics LLCINDUSTRY | 1 | Oct 18, 2023 | clinicaltrials |
| NCT04115527 | Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma. | unknown | N/A | 100 | Ruijin HospitalOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT05363007 | Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma(SINAI) | unknown | Phase 2 | 60 | National Taiwan University HospitalOTHER | 1 | Oct 16, 2023 | clinicaltrials |
| NCT06054984 | TCR-T Cells in the Treatment of Advanced Pancreatic Cancer(GB3010-02) | unknown | Early Phase 1 | 18 | Ruijin HospitalOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT06080854 | AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer | unknown | Phase 2 | 108 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT04303403 | Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma | unknown | Phase 1 | 48 | National Cancer Centre, SingaporeOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT02184663 | Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer | unknown | N/A | 313 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT03382340 | IMX-110 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 70 | Immix Biopharma Australia Pty LtdINDUSTRY | 2 | Sep 28, 2023 | clinicaltrials |
| NCT04033107 | High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors | unknown | Phase 2 | 30 | Zhongnan HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT04979611 | The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma | unknown | Phase 1 | 60 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06048458 | Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping(PC-TOX) | unknown | — | 75 | University College, LondonOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT05914077 | Aspiration of Duodenopancreatic Juice After Secretin Stimulation vs Endoscopic Aspiration for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia.(RESCUE) | unknown | Phase 3 | 140 | Fundacion Clinic per a la Recerca BiomédicaOTHER | 1 | Sep 18, 2023 | clinicaltrials |
| NCT05907824 | Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm | unknown | — | 800 | Fudan UniversityOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT05271344 | Oral Immunonutrition With Synbiotics, Omega 3 and Vitamin D in Patients Undergoing Duodenopancreatectomy for Tumoral Lesion.(SIO3D) | unknown | N/A | 74 | Centre Hospitalier Universitaire de LiegeOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT03777462 | Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1(BRPCNCC-1) | unknown | Phase 2 | 150 | Changhai HospitalOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT04324307 | Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 60 | Changhai HospitalOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT04373928 | Personalized Precision Diagnosis and Treatment of Pancreatic Cancer(PPDTPC) | unknown | N/A | 100 | Changhai HospitalOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT04902261 | Tislelizumab Combined With Nab-paclitaxel and Gemcitabine for Recurrent Pancreatic Cancer | unknown | Phase 2 | 140 | Changhai HospitalOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT05783076 | SBRT Plus vNKT for Pancreatic Cancer | unknown | Phase 2 | 29 | Changhai HospitalOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT05997147 | A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma | unknown | — | 1,009 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05977777 | Contrast-enhanced Ultrasound and Pancreatic Lesions | unknown | N/A | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT05703581 | Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal Pancreatectomy | unknown | — | 200 | Fudan UniversityOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05959395 | Hyperthermia Treatment Added to Chemotherapy Standard of Care for Pancreatic Tumors | unknown | N/A | 5 | NeoTherma OncologyINDUSTRY | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05957250 | [68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer(PANSCAN-1) | unknown | N/A | 63 | Amsterdam UMC, location VUmcOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05955092 | Exploring the Application of 3D Bioprinting for Personalized Treatment in Pancreatic Ductal Adenocarcinoma | unknown | — | 30 | Peking Union Medical College HospitalOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05595122 | EUS-guided Choledochoduodenostomy for Primary Drainage of Malignant Distal Biliary Obstruction(SCORPION-II-p) | unknown | N/A | 25 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jul 20, 2023 | clinicaltrials |
| NCT05223218 | Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study | unknown | — | 500 | Namida LabINDUSTRY | 1 | Jul 3, 2023 | clinicaltrials |
| NCT05549960 | Pre-planning Mathematical Models in EUS-guided Laser Ablation of Pancreatic Lesions(LA-EUS MOD) | unknown | N/A | 10 | Campus Bio-Medico UniversityOTHER | 1 | Jul 3, 2023 | clinicaltrials |
| NCT04803851 | Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 29 | Peking Union Medical College HospitalOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT03809247 | Microbial Diversity of Pancreatic Diseases | unknown | — | 330 | Ruijin HospitalOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05193162 | Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases | unknown | — | 800 | Ruijin HospitalOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05681390 | Tislelizumab With Anlotinib and Chemotherapy for Second-line Treatment of Pancreatic Cancer | unknown | Phase 2 | 30 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT05886075 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | unknown | Early Phase 1 | 24 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jun 2, 2023 | clinicaltrials |
| NCT05393986 | Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors | unknown | Phase 1 | 63 | Peking UniversityOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05754788 | Gene Expression Profile of Resected Pancreatic and Ampullary Adenocarcinoma at Favorable Prognosis | unknown | — | 40 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 26, 2023 | clinicaltrials |
| NCT02745847 | Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer | unknown | N/A | 30 | Changhai HospitalOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05875753 | 68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer | unknown | Early Phase 1 | 50 | Peking Union Medical College HospitalOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT03553004 | Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial(NIRA-PANC) | unknown | Phase 2 | 18 | University of Kansas Medical CenterOTHER | 1 | May 19, 2023 | clinicaltrials |
| NCT05860374 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | May 16, 2023 | clinicaltrials |
| NCT04855331 | Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC | unknown | N/A | 120 | Fudan UniversityOTHER | 1 | May 9, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Nov 28, 2023source: clinicaltrials